The board of directors of Eris Lifesciences approved the buyback of the fully paid 17,39,130 equity shares of Re. 1 each. The buyback was initiated at a price of Rs. 575 per share, thereby resulting in a maximum consideration amount not exceeding Rs. 100 crore.